Anyone else notice this on Page 1?
The RAC-006 study has received human ethics approval and is expected to enrol the first patient in CY2023 (ASX Announcements: 6 April
2022).
Dr T often reminds us to read every single line carefully and they easily could have omitted this reference given it's already the 22nd of December! Therefore, I am wondering if they have screened a suitable AML patient who has the EMD form, but are yet to start treatment. Hence, the no announcement on 'first patient treated' just yet. Perhaps we can expect this announcement in Jan?
Ann: Race supports Study of Extramedullary AML, page-12
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
-0.020(1.19%) |
Mkt cap ! $282.8M | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.67 | $1.61 | $153.5K | 94.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.67 | 4080 | 1 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |